Occudo Quantitative Strategies LP Olema Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.22 - $9.65 $57,692 - $172,899	17,917 New	17,917 $161,000
Q4 2022 Feb 14, 2023	SELL	$2.27 - $3.76 $7,559 - $12,520	-3,330 Reduced 16.94%	16,322 $39,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.88 $57,919 - $125,208	-21,294 Reduced 52.01%	19,652 $54,000
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.61 $38,511 - $87,027	-18,878 Reduced 31.56%	40,946 $167,000
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $67,604 - $163,883	-17,379 Reduced 22.51%	59,824 $255,000
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $675,526 - $2.37 Million	77,203 New	77,203 $723,000

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.